Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Vaxcyte, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 251
- +30 vs. Q4 2023
- Shares held
- 119.1M
- +16.3M (+15.8%) vs. Q4 2023
- Total value
- $8.13B
- +$1.67B (+25.9%) vs. Q4 2023
- New holders
- 48
- 102 more added
- Sold out
- 18
- 77 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 331 | $9.71B |
| Q1 2026 | 336 | $9.44B |
| Q4 2025 | 295 | $6.81B |
| Q3 2025 | 285 | $5.09B |
| Q2 2025 | 294 | $4.80B |
| Q1 2025 | 315 | $5.88B |
| Q4 2024 | 323 | $11.5B |
| Q3 2024 | 329 | $15.6B |
| Q2 2024 | 265 | $9.26B |
| Q1 2024 | 251 | $8.13B |
| Q4 2023 | 223 | $6.47B |
| Q3 2023 | 202 | $5.17B |
| Q2 2023 | 197 | $5.00B |
| Q1 2023 | 188 | $3.15B |
| Q4 2022 | 198 | $3.91B |
| Q3 2022 | 126 | $1.36B |
| Q2 2022 | 106 | $1.12B |
| Q1 2022 | 88 | $1.20B |
| Q4 2021 | 87 | $1.06B |
| Q3 2021 | 78 | $1.10B |
| Q2 2021 | 75 | $972.7M |
| Q1 2021 | 74 | $869.2M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Vaxcyte, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 300,000 | $20.5M | 0.52% | +300,000 | New |
| Samlyn Capital, LLC | 302,679 | $20.7M | 0.36% | −26,530−8.1% | Reduced |
| Nuveen Asset Management, LLC | 311,352 | $21.3M | 0.01% | +30,496+10.9% | Added |
| Eagle Asset Management Inc | 338,800 | $22.6M | 0.11% | −15,323−4.3% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 355,131 | $24.3M | 0.47% | +355,131 | New |
| D. E. Shaw & Co., Inc. | 367,249 | $25.1M | 0.03% | −71,062−16.2% | Reduced |
| Farallon Capital Management, L.L.C. | 377,400 | $25.8M | 0.15% | +374,000+11,000.0% | Added |
| Lord, Abbett & Co. LLC | 384,363 | $26.3M | 0.08% | −1,211−0.3% | Reduced |
| Woodline Partners LP | 393,704 | $26.9M | 0.25% | +353+0.1% | Added |
| Bank of New York Mellon Corp | 412,525 | $28.2M | 0.01% | +13,408+3.4% | Added |
| Federated Hermes, Inc. | 425,750 | $29.1M | 0.07% | +31,558+8.0% | Added |
| American Century Companies Inc | 461,724 | $31.5M | 0.02% | +54,495+13.4% | Added |
| Ensign Peak Advisors, Inc | 475,700 | $32.5M | 0.06% | +114,569+31.7% | Added |
| Morgan Stanley | 490,454 | $33.5M | 0.00% | −46,911−8.7% | Reduced |
| Avoro Capital Advisors LLC | 575,000 | $39.3M | 0.46% | +575,000 | New |
| Eventide Asset Management, LLC | 657,206 | $44.9M | 0.70% | +50,000+8.2% | Added |
| Cormorant Asset Management, LP | 685,000 | $46.8M | 2.06% | +20,000+3.0% | Added |
| Goldman Sachs Group Inc | 698,492 | $47.7M | 0.01% | +217,373+45.2% | Added |
| Kynam Capital Management, LP | 745,000 | $50.9M | 5.66% | −257,407−25.7% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $54.2M | 34.82% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 833,618 | $56.9M | 0.01% | +103,180+14.1% | Added |
| Novo Holdings A/S | 845,000 | $57.7M | 3.98% | 00.0% | Unchanged |
| Commodore Capital LP | 860,000 | $58.7M | 3.93% | −240,000−21.8% | Reduced |
| Pictet Asset Management Holding SA | 861,569 | $58.9M | 0.06% | −287,640−25.0% | Reduced |
| Northern Trust Corp | 968,757 | $66.2M | 0.01% | +84,489+9.6% | Added |
| Norges Bank | 1,046,032 | $71.5M | 0.01% | +130,520+14.3% | Added |
| OrbiMed Advisors LLC | 1,066,131 | $72.8M | 1.43% | −86,960−7.5% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,139,405 | $77.8M | 3.28% | −25,000−2.1% | Reduced |
| JPMorgan Chase & Co | 1,161,777 | $79.4M | 0.01% | +756,443+186.6% | Added |
| Braidwell LP | 1,212,703 | $82.8M | 2.67% | −77,262−6.0% | Reduced |
| Invesco Ltd. | 1,234,509 | $84.3M | 0.02% | +1,007,558+444.0% | Added |
| Paradigm Biocapital Advisors LP | 1,239,995 | $84.7M | 2.98% | +1,239,995 | New |
| Jennison Associates LLC | 1,256,883 | $85.9M | 0.06% | −219,271−14.9% | Reduced |
| Fred Alger Management, LLC | 1,396,711 | $95.4M | 0.47% | −273,478−16.4% | Reduced |
| Westfield Capital Management Co LP | 1,586,095 | $108.3M | 0.57% | +130,502+9.0% | Added |
| Alliancebernstein L.P. | 1,780,703 | $121.6M | 0.04% | −134,344−7.0% | Reduced |
| Driehaus Capital Management LLC | 1,867,807 | $127.6M | 1.27% | +193,439+11.6% | Added |
| Perceptive Advisors LLC | 1,932,759 | $132.0M | 2.33% | +844,273+77.6% | Added |
| Franklin Resources Inc | 2,147,656 | $146.7M | 0.05% | +1,070,736+99.4% | Added |
| Geode Capital Management, LLC | 2,287,375 | $156.3M | 0.01% | +313,869+15.9% | Added |
| Darwin Global Management, Ltd. | 2,750,804 | $187.9M | 25.02% | +2,170,845+374.3% | Added |
| Price T Rowe Associates Inc | 3,176,181 | $217.0M | 0.03% | +498,359+18.6% | Added |
| State Street Corp | 3,337,092 | $228.0M | 0.01% | −52,436−1.5% | Reduced |
| T. Rowe Price Investment Management, Inc. | 3,552,967 | $242.7M | 0.15% | +2,306,926+185.1% | Added |
| Capital Research Global Investors | 4,140,521 | $282.8M | 0.06% | +700,414+20.4% | Added |
| Wellington Management Group LLP | 4,919,370 | $336.0M | 0.06% | +487,450+11.0% | Added |
| Janus Henderson Group PLC | 7,673,868 | $524.1M | 0.29% | +692,492+9.9% | Added |
| Ra Capital Management, L.P. | 8,203,754 | $560.4M | 7.13% | +312,500+4.0% | Added |
| BlackRock Inc. | 9,513,007 | $649.8M | 0.02% | +937,160+10.9% | Added |
| Vanguard Group Inc | 9,737,254 | $665.2M | 0.01% | +1,284,883+15.2% | Added |
| FMR LLC | 16,261,159 | $1.11B | 0.07% | +2,047,794+14.4% | Added |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −525,000−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −360,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −91,198−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −38,092−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −30,155−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −17,706−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −17,694−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −17,461−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −12,859−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −11,869−100.0% | Sold out |
| Ellsworth Advisors, LLC | 0 | $0 | 0.00% | −8,060−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −6,741−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −5,820−100.0% | Sold out |
| Oppenheimer Asset Management Inc. | 0 | $0 | 0.00% | −3,198−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −932−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |